Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 58, Issue 8, Pages 1931-1940
Publisher
Informa UK Limited
Online
2016-12-19
DOI
10.1080/10428194.2016.1266621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal heterogeneity in plasma cell myeloma
- (2016) Jason George Quinn et al. LANCET
- New criteria for response assessment: role of minimal residual disease in multiple myeloma
- (2015) B. Paiva et al. BLOOD
- Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors
- (2015) A K Mitra et al. LEUKEMIA
- Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease
- (2014) A. Garcia-Gomez et al. CLINICAL CANCER RESEARCH
- Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential
- (2014) T Paíno et al. LEUKEMIA
- Utilization of Translational Bioinformatics to Identify Novel Biomarkers of Bortezomib Resistance in Multiple Myeloma
- (2014) Deanna J. Fall et al. Journal of Cancer
- Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study
- (2013) Wenli Zheng et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib
- (2013) H A F Stessman et al. LEUKEMIA
- Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
- (2013) Joseph R. Mikhael et al. MAYO CLINIC PROCEEDINGS
- Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model
- (2013) H. A. F. Stessman et al. MOLECULAR CANCER THERAPEUTICS
- viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
- (2013) El-ad David Amir et al. NATURE BIOTECHNOLOGY
- Bortezomib Resistance Can Be Reversed by Induced Expression of Plasma Cell Maturation Markers in a Mouse In Vitro Model of Multiple Myeloma
- (2013) Holly A. F. Stessman et al. PLoS One
- A deep profiler's guide to cytometry
- (2012) Sean C. Bendall et al. TRENDS IN IMMUNOLOGY
- Flow cytometry in the post fluorescence era
- (2011) Garry P. Nolan BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Carfilzomib: a novel second-generation proteasome inhibitor
- (2011) Meaghan L Khan et al. Future Oncology
- Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE
- (2011) Peng Qiu et al. NATURE BIOTECHNOLOGY
- CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?
- (2010) Cindy Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
- (2008) B. Paiva et al. BLOOD
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started